Bio updated March 2014 (printable PDF)
Curriulum Vitae (CV) updated January 2014 (printable PDF)
Board-Certified Family Physician
Diplomate, American Board of Clinical Lipidology
Chief Medical Officer, Health Diagnostic Laboratory, Inc.
One of the first things Dr. Tara Dall will mention when you meet her is that she’s practiced and advocated for advanced, comprehensive laboratory testing for her entire career. “Very, very few patients have had a heart attack on my watch and when they do I feel I’ve personally failed them,” Dall says. “Heart disease is a global crisis, yet it is a treatable, preventable disease.”
With a family history of cardiovascular disease and diabetes, the issue is one that the Chief Medical Officer of Health Diagnostic Laboratory, Inc. takes personally, empowering her professional career and life’s journey. After attending the University of Wisconsin-Madison for her undergraduate and medical school education and family medicine residency, Dall entered private practice in 2001 and formed the Cholesterol & Lifestyle Center a few years later with the goal of aggressive detection and treatment of atherosclerotic cardiovascular disease. She graduated in the inaugural class of Diplomates of the American Board of Clinical Lipidology in 2005. Her center achieved national recognition as the first fully certified Level II lipid clinic in the United States.
In 2008, Dall formed Advanced Lipidology, an early detection center for heart disease and diabetes near Madison, Wisconsin. Two years later, she brought her fight against heart disease to the web, co-founding Lecturepad.org and CaseConsult.org, web platforms that advance clinical understanding and application of advanced lipid and biomarker testing.
In 2012 Dall joined Virginia-based HDL, Inc. There, she has led the medical team at the advanced cardiometabolic testing and health management company to new heights, expanding its assays and panels and co-authoring research focused on the role that insulin resistance plays in diabetes prevention. She has a special interest in insulin resistance’s role in cardiovascular disease, women's heart disease, polycystic ovarian syndrome, and childhood obesity. She also serves as Chief of cardiometabolic education at the non-profit Foundation for Health Improvement and Technology (FHIT) – all while continuing to straddle both Wisconsin and Virginia.
Known for her passionate delivery of complex medical topics in patient-friendly terms, Dall travels the world to present research on advanced biomarkers and educates physicians around the U.S. at continuing medical education events on the importance of going beyond cholesterol and considering the role, for example, of apolipoprotein-B, LDL particle concentration and LDL particle size in the development of heart disease and diabetes. Dr. Dall is a regular go-to for reporters and has been quoted in Bloomberg News and CBS Sports regarding her role in HDL, Inc.’s testing and partnership with the Washington Redskins NFL team. She has appeared on CNN Radio, Reach MD Satellite Radio, RadioHealth Journal, KTXD-TV’s The Broadcast in Dallas, and many local media outlets.
Dall considers it a blessing to be part of a movement in medicine that will change the way physicians treat patients and assess their risk, but she knows that it’s both an opportunity and a challenge. “The public needs to know about advanced biomarker testing, and I am on a mission to educate consumers, insurance companies, employers, governments and practicing physicians. We can prevent heart disease and diabetes and dramatically reduce health care costs, but we need to step out of our traditional paradigm of thinking,” Dall told the Richmond (Va.) Times-Dispatch in 2013. “I’m so optimistic it will happen despite the challenges that lay ahead.”